nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—ABCB1—lung cancer	0.164	1	CbGaD
Boceprevir—CYP3A5—Gefitinib—lung cancer	0.032	0.0752	CbGbCtD
Boceprevir—CYP3A5—Teniposide—lung cancer	0.031	0.0729	CbGbCtD
Boceprevir—ABCB1—Topotecan—lung cancer	0.0227	0.0535	CbGbCtD
Boceprevir—ABCB1—Gefitinib—lung cancer	0.0208	0.0489	CbGbCtD
Boceprevir—CYP3A5—Crizotinib—lung cancer	0.0196	0.0461	CbGbCtD
Boceprevir—CYP3A5—Erlotinib—lung cancer	0.0189	0.0444	CbGbCtD
Boceprevir—CYP3A5—Paclitaxel—lung cancer	0.0173	0.0407	CbGbCtD
Boceprevir—CYP3A5—Irinotecan—lung cancer	0.0171	0.0401	CbGbCtD
Boceprevir—ABCB1—Vinorelbine—lung cancer	0.016	0.0377	CbGbCtD
Boceprevir—CYP3A5—Etoposide—lung cancer	0.0137	0.0321	CbGbCtD
Boceprevir—CYP3A4—Topotecan—lung cancer	0.0136	0.032	CbGbCtD
Boceprevir—ABCB1—Crizotinib—lung cancer	0.0127	0.03	CbGbCtD
Boceprevir—CYP3A5—Docetaxel—lung cancer	0.0125	0.0294	CbGbCtD
Boceprevir—CYP3A4—Gefitinib—lung cancer	0.0125	0.0293	CbGbCtD
Boceprevir—ABCB1—Gemcitabine—lung cancer	0.0125	0.0293	CbGbCtD
Boceprevir—ABCB1—Erlotinib—lung cancer	0.0123	0.0289	CbGbCtD
Boceprevir—CYP3A4—Teniposide—lung cancer	0.0121	0.0284	CbGbCtD
Boceprevir—ABCB1—Paclitaxel—lung cancer	0.0113	0.0265	CbGbCtD
Boceprevir—ABCB1—Irinotecan—lung cancer	0.0111	0.0261	CbGbCtD
Boceprevir—ABCB1—Vinblastine—lung cancer	0.00987	0.0232	CbGbCtD
Boceprevir—CYP3A4—Vinorelbine—lung cancer	0.0096	0.0226	CbGbCtD
Boceprevir—ABCB1—Cisplatin—lung cancer	0.00905	0.0213	CbGbCtD
Boceprevir—ABCB1—Etoposide—lung cancer	0.00889	0.0209	CbGbCtD
Boceprevir—ABCB1—Docetaxel—lung cancer	0.00814	0.0191	CbGbCtD
Boceprevir—CYP3A4—Crizotinib—lung cancer	0.00764	0.018	CbGbCtD
Boceprevir—CYP3A4—Erlotinib—lung cancer	0.00737	0.0173	CbGbCtD
Boceprevir—CYP3A4—Paclitaxel—lung cancer	0.00674	0.0159	CbGbCtD
Boceprevir—CYP3A4—Irinotecan—lung cancer	0.00665	0.0156	CbGbCtD
Boceprevir—ABCB1—Doxorubicin—lung cancer	0.00607	0.0143	CbGbCtD
Boceprevir—CYP3A4—Vinblastine—lung cancer	0.00592	0.0139	CbGbCtD
Boceprevir—ABCB1—Methotrexate—lung cancer	0.00588	0.0138	CbGbCtD
Boceprevir—CYP3A4—Etoposide—lung cancer	0.00533	0.0125	CbGbCtD
Boceprevir—CYP3A4—Docetaxel—lung cancer	0.00488	0.0115	CbGbCtD
Boceprevir—CMA1—respiratory system—lung cancer	0.00398	0.0609	CbGeAlD
Boceprevir—CTSK—mammary gland—lung cancer	0.00384	0.0588	CbGeAlD
Boceprevir—CYP3A4—Doxorubicin—lung cancer	0.00363	0.00855	CbGbCtD
Boceprevir—CTSV—bronchus—lung cancer	0.00343	0.0524	CbGeAlD
Boceprevir—CTSL—respiratory system—lung cancer	0.0034	0.0521	CbGeAlD
Boceprevir—CTSV—trachea—lung cancer	0.00308	0.0471	CbGeAlD
Boceprevir—CTSL—epithelium—lung cancer	0.00284	0.0435	CbGeAlD
Boceprevir—CTSL—bronchus—lung cancer	0.0028	0.0428	CbGeAlD
Boceprevir—CTSK—respiratory system—lung cancer	0.00256	0.0392	CbGeAlD
Boceprevir—CTSL—trachea—lung cancer	0.00251	0.0385	CbGeAlD
Boceprevir—CTSL—cardiac atrium—lung cancer	0.00236	0.0361	CbGeAlD
Boceprevir—CMA1—bone marrow—lung cancer	0.00233	0.0357	CbGeAlD
Boceprevir—CTSS—respiratory system—lung cancer	0.00224	0.0344	CbGeAlD
Boceprevir—CTSV—lung—lung cancer	0.00221	0.0338	CbGeAlD
Boceprevir—CMA1—lung—lung cancer	0.00211	0.0323	CbGeAlD
Boceprevir—CTSK—bronchus—lung cancer	0.00211	0.0323	CbGeAlD
Boceprevir—CTSL—bone marrow—lung cancer	0.00199	0.0305	CbGeAlD
Boceprevir—CTSK—trachea—lung cancer	0.00189	0.029	CbGeAlD
Boceprevir—CTSS—bronchus—lung cancer	0.00185	0.0283	CbGeAlD
Boceprevir—CTSL—lung—lung cancer	0.00181	0.0276	CbGeAlD
Boceprevir—CTSK—cardiac atrium—lung cancer	0.00178	0.0272	CbGeAlD
Boceprevir—CTSS—trachea—lung cancer	0.00166	0.0254	CbGeAlD
Boceprevir—CTSK—bone marrow—lung cancer	0.0015	0.023	CbGeAlD
Boceprevir—CMA1—lymph node—lung cancer	0.00144	0.0221	CbGeAlD
Boceprevir—CTSK—lung—lung cancer	0.00136	0.0208	CbGeAlD
Boceprevir—CTSS—bone marrow—lung cancer	0.00132	0.0201	CbGeAlD
Boceprevir—Telaprevir—ALB—lung cancer	0.00128	0.512	CrCbGaD
Boceprevir—CTSL—lymph node—lung cancer	0.00123	0.0189	CbGeAlD
Boceprevir—Telaprevir—ABCB1—lung cancer	0.00122	0.488	CrCbGaD
Boceprevir—CTSS—lung—lung cancer	0.00119	0.0182	CbGeAlD
Boceprevir—CTSK—lymph node—lung cancer	0.00093	0.0142	CbGeAlD
Boceprevir—CTSS—lymph node—lung cancer	0.000815	0.0125	CbGeAlD
Boceprevir—CYP3A5—respiratory system—lung cancer	0.000746	0.0114	CbGeAlD
Boceprevir—ABCB1—respiratory system—lung cancer	0.000396	0.00606	CbGeAlD
Boceprevir—CYP3A5—lung—lung cancer	0.000396	0.00606	CbGeAlD
Boceprevir—ABCB1—epithelium—lung cancer	0.000331	0.00507	CbGeAlD
Boceprevir—ABCB1—trachea—lung cancer	0.000293	0.00448	CbGeAlD
Boceprevir—ABCB1—bone marrow—lung cancer	0.000232	0.00355	CbGeAlD
Boceprevir—ABCB1—lung—lung cancer	0.00021	0.00322	CbGeAlD
Boceprevir—ABCB1—lymph node—lung cancer	0.000144	0.0022	CbGeAlD
Boceprevir—Pain—Etoposide—lung cancer	5.75e-05	0.000297	CcSEcCtD
Boceprevir—Constipation—Etoposide—lung cancer	5.75e-05	0.000297	CcSEcCtD
Boceprevir—Dysuria—Doxorubicin—lung cancer	5.73e-05	0.000296	CcSEcCtD
Boceprevir—Neutropenia—Doxorubicin—lung cancer	5.73e-05	0.000296	CcSEcCtD
Boceprevir—Decreased appetite—Paclitaxel—lung cancer	5.73e-05	0.000296	CcSEcCtD
Boceprevir—Dry mouth—Docetaxel—lung cancer	5.7e-05	0.000295	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Paclitaxel—lung cancer	5.69e-05	0.000294	CcSEcCtD
Boceprevir—Fatigue—Paclitaxel—lung cancer	5.68e-05	0.000294	CcSEcCtD
Boceprevir—Pollakiuria—Doxorubicin—lung cancer	5.66e-05	0.000293	CcSEcCtD
Boceprevir—Asthenia—Gemcitabine—lung cancer	5.65e-05	0.000292	CcSEcCtD
Boceprevir—Constipation—Paclitaxel—lung cancer	5.63e-05	0.000291	CcSEcCtD
Boceprevir—Pain—Paclitaxel—lung cancer	5.63e-05	0.000291	CcSEcCtD
Boceprevir—Confusional state—Docetaxel—lung cancer	5.63e-05	0.000291	CcSEcCtD
Boceprevir—Pharyngitis—Methotrexate—lung cancer	5.62e-05	0.000291	CcSEcCtD
Boceprevir—Urinary tract disorder—Methotrexate—lung cancer	5.59e-05	0.000289	CcSEcCtD
Boceprevir—Photosensitivity reaction—Doxorubicin—lung cancer	5.59e-05	0.000289	CcSEcCtD
Boceprevir—Pruritus—Gemcitabine—lung cancer	5.57e-05	0.000288	CcSEcCtD
Boceprevir—Urethral disorder—Methotrexate—lung cancer	5.55e-05	0.000287	CcSEcCtD
Boceprevir—Infection—Docetaxel—lung cancer	5.55e-05	0.000287	CcSEcCtD
Boceprevir—Weight decreased—Doxorubicin—lung cancer	5.54e-05	0.000287	CcSEcCtD
Boceprevir—Feeling abnormal—Etoposide—lung cancer	5.54e-05	0.000286	CcSEcCtD
Boceprevir—Hyperglycaemia—Doxorubicin—lung cancer	5.53e-05	0.000286	CcSEcCtD
Boceprevir—Diarrhoea—Irinotecan—lung cancer	5.53e-05	0.000286	CcSEcCtD
Boceprevir—Pneumonia—Doxorubicin—lung cancer	5.5e-05	0.000284	CcSEcCtD
Boceprevir—Gastrointestinal pain—Etoposide—lung cancer	5.49e-05	0.000284	CcSEcCtD
Boceprevir—Shock—Docetaxel—lung cancer	5.49e-05	0.000284	CcSEcCtD
Boceprevir—Nervous system disorder—Docetaxel—lung cancer	5.48e-05	0.000283	CcSEcCtD
Boceprevir—Thrombocytopenia—Docetaxel—lung cancer	5.47e-05	0.000283	CcSEcCtD
Boceprevir—Infestation—Doxorubicin—lung cancer	5.46e-05	0.000282	CcSEcCtD
Boceprevir—Infestation NOS—Doxorubicin—lung cancer	5.46e-05	0.000282	CcSEcCtD
Boceprevir—Visual impairment—Methotrexate—lung cancer	5.46e-05	0.000282	CcSEcCtD
Boceprevir—Tachycardia—Docetaxel—lung cancer	5.45e-05	0.000282	CcSEcCtD
Boceprevir—Feeling abnormal—Paclitaxel—lung cancer	5.43e-05	0.000281	CcSEcCtD
Boceprevir—Skin disorder—Docetaxel—lung cancer	5.42e-05	0.00028	CcSEcCtD
Boceprevir—Stevens-Johnson syndrome—Doxorubicin—lung cancer	5.42e-05	0.00028	CcSEcCtD
Boceprevir—Hypersensitivity—Cisplatin—lung cancer	5.4e-05	0.000279	CcSEcCtD
Boceprevir—Gastrointestinal pain—Paclitaxel—lung cancer	5.39e-05	0.000278	CcSEcCtD
Boceprevir—Diarrhoea—Gemcitabine—lung cancer	5.38e-05	0.000278	CcSEcCtD
Boceprevir—Erythema multiforme—Methotrexate—lung cancer	5.36e-05	0.000277	CcSEcCtD
Boceprevir—Neuropathy peripheral—Doxorubicin—lung cancer	5.36e-05	0.000277	CcSEcCtD
Boceprevir—Dizziness—Irinotecan—lung cancer	5.34e-05	0.000276	CcSEcCtD
Boceprevir—Urticaria—Etoposide—lung cancer	5.34e-05	0.000276	CcSEcCtD
Boceprevir—Stomatitis—Doxorubicin—lung cancer	5.33e-05	0.000275	CcSEcCtD
Boceprevir—Body temperature increased—Etoposide—lung cancer	5.31e-05	0.000275	CcSEcCtD
Boceprevir—Abdominal pain—Etoposide—lung cancer	5.31e-05	0.000275	CcSEcCtD
Boceprevir—Urinary tract infection—Doxorubicin—lung cancer	5.31e-05	0.000275	CcSEcCtD
Boceprevir—Conjunctivitis—Doxorubicin—lung cancer	5.31e-05	0.000275	CcSEcCtD
Boceprevir—Eye disorder—Methotrexate—lung cancer	5.29e-05	0.000274	CcSEcCtD
Boceprevir—Tinnitus—Methotrexate—lung cancer	5.28e-05	0.000273	CcSEcCtD
Boceprevir—Asthenia—Cisplatin—lung cancer	5.26e-05	0.000272	CcSEcCtD
Boceprevir—Cardiac disorder—Methotrexate—lung cancer	5.26e-05	0.000272	CcSEcCtD
Boceprevir—Urticaria—Paclitaxel—lung cancer	5.23e-05	0.000271	CcSEcCtD
Boceprevir—Hypotension—Docetaxel—lung cancer	5.22e-05	0.00027	CcSEcCtD
Boceprevir—Abdominal pain—Paclitaxel—lung cancer	5.21e-05	0.000269	CcSEcCtD
Boceprevir—Body temperature increased—Paclitaxel—lung cancer	5.21e-05	0.000269	CcSEcCtD
Boceprevir—Hepatobiliary disease—Doxorubicin—lung cancer	5.17e-05	0.000267	CcSEcCtD
Boceprevir—Epistaxis—Doxorubicin—lung cancer	5.15e-05	0.000266	CcSEcCtD
Boceprevir—Angiopathy—Methotrexate—lung cancer	5.14e-05	0.000266	CcSEcCtD
Boceprevir—Vomiting—Irinotecan—lung cancer	5.14e-05	0.000266	CcSEcCtD
Boceprevir—Sinusitis—Doxorubicin—lung cancer	5.13e-05	0.000265	CcSEcCtD
Boceprevir—Immune system disorder—Methotrexate—lung cancer	5.12e-05	0.000265	CcSEcCtD
Boceprevir—Mediastinal disorder—Methotrexate—lung cancer	5.11e-05	0.000264	CcSEcCtD
Boceprevir—Agranulocytosis—Doxorubicin—lung cancer	5.1e-05	0.000264	CcSEcCtD
Boceprevir—Rash—Irinotecan—lung cancer	5.09e-05	0.000263	CcSEcCtD
Boceprevir—Dermatitis—Irinotecan—lung cancer	5.09e-05	0.000263	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Docetaxel—lung cancer	5.09e-05	0.000263	CcSEcCtD
Boceprevir—Chills—Methotrexate—lung cancer	5.08e-05	0.000263	CcSEcCtD
Boceprevir—Headache—Irinotecan—lung cancer	5.06e-05	0.000262	CcSEcCtD
Boceprevir—Insomnia—Docetaxel—lung cancer	5.05e-05	0.000261	CcSEcCtD
Boceprevir—Diarrhoea—Cisplatin—lung cancer	5.02e-05	0.000259	CcSEcCtD
Boceprevir—Paraesthesia—Docetaxel—lung cancer	5.01e-05	0.000259	CcSEcCtD
Boceprevir—Alopecia—Methotrexate—lung cancer	5.01e-05	0.000259	CcSEcCtD
Boceprevir—Vomiting—Gemcitabine—lung cancer	5e-05	0.000259	CcSEcCtD
Boceprevir—Dyspnoea—Docetaxel—lung cancer	4.98e-05	0.000257	CcSEcCtD
Boceprevir—Mental disorder—Methotrexate—lung cancer	4.96e-05	0.000257	CcSEcCtD
Boceprevir—Rash—Gemcitabine—lung cancer	4.96e-05	0.000256	CcSEcCtD
Boceprevir—Dermatitis—Gemcitabine—lung cancer	4.96e-05	0.000256	CcSEcCtD
Boceprevir—Hypersensitivity—Etoposide—lung cancer	4.95e-05	0.000256	CcSEcCtD
Boceprevir—Malnutrition—Methotrexate—lung cancer	4.93e-05	0.000255	CcSEcCtD
Boceprevir—Erythema—Methotrexate—lung cancer	4.93e-05	0.000255	CcSEcCtD
Boceprevir—Headache—Gemcitabine—lung cancer	4.93e-05	0.000255	CcSEcCtD
Boceprevir—Rhinitis—Doxorubicin—lung cancer	4.92e-05	0.000254	CcSEcCtD
Boceprevir—Dyspepsia—Docetaxel—lung cancer	4.92e-05	0.000254	CcSEcCtD
Boceprevir—Hypoaesthesia—Doxorubicin—lung cancer	4.88e-05	0.000252	CcSEcCtD
Boceprevir—Pharyngitis—Doxorubicin—lung cancer	4.87e-05	0.000252	CcSEcCtD
Boceprevir—Decreased appetite—Docetaxel—lung cancer	4.85e-05	0.000251	CcSEcCtD
Boceprevir—Hypersensitivity—Paclitaxel—lung cancer	4.85e-05	0.000251	CcSEcCtD
Boceprevir—Urinary tract disorder—Doxorubicin—lung cancer	4.84e-05	0.00025	CcSEcCtD
Boceprevir—Oedema peripheral—Doxorubicin—lung cancer	4.83e-05	0.00025	CcSEcCtD
Boceprevir—Dysgeusia—Methotrexate—lung cancer	4.83e-05	0.00025	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Docetaxel—lung cancer	4.82e-05	0.000249	CcSEcCtD
Boceprevir—Asthenia—Etoposide—lung cancer	4.82e-05	0.000249	CcSEcCtD
Boceprevir—Connective tissue disorder—Doxorubicin—lung cancer	4.82e-05	0.000249	CcSEcCtD
Boceprevir—Fatigue—Docetaxel—lung cancer	4.81e-05	0.000249	CcSEcCtD
Boceprevir—Urethral disorder—Doxorubicin—lung cancer	4.81e-05	0.000249	CcSEcCtD
Boceprevir—Nausea—Irinotecan—lung cancer	4.8e-05	0.000248	CcSEcCtD
Boceprevir—Constipation—Docetaxel—lung cancer	4.77e-05	0.000247	CcSEcCtD
Boceprevir—Pain—Docetaxel—lung cancer	4.77e-05	0.000247	CcSEcCtD
Boceprevir—Back pain—Methotrexate—lung cancer	4.77e-05	0.000247	CcSEcCtD
Boceprevir—Pruritus—Etoposide—lung cancer	4.75e-05	0.000246	CcSEcCtD
Boceprevir—Visual impairment—Doxorubicin—lung cancer	4.73e-05	0.000244	CcSEcCtD
Boceprevir—Asthenia—Paclitaxel—lung cancer	4.73e-05	0.000244	CcSEcCtD
Boceprevir—Nausea—Gemcitabine—lung cancer	4.67e-05	0.000242	CcSEcCtD
Boceprevir—Vomiting—Cisplatin—lung cancer	4.66e-05	0.000241	CcSEcCtD
Boceprevir—Pruritus—Paclitaxel—lung cancer	4.66e-05	0.000241	CcSEcCtD
Boceprevir—Vision blurred—Methotrexate—lung cancer	4.65e-05	0.00024	CcSEcCtD
Boceprevir—Erythema multiforme—Doxorubicin—lung cancer	4.64e-05	0.00024	CcSEcCtD
Boceprevir—Rash—Cisplatin—lung cancer	4.62e-05	0.000239	CcSEcCtD
Boceprevir—Dermatitis—Cisplatin—lung cancer	4.62e-05	0.000239	CcSEcCtD
Boceprevir—Feeling abnormal—Docetaxel—lung cancer	4.6e-05	0.000238	CcSEcCtD
Boceprevir—Diarrhoea—Etoposide—lung cancer	4.6e-05	0.000238	CcSEcCtD
Boceprevir—Eye disorder—Doxorubicin—lung cancer	4.58e-05	0.000237	CcSEcCtD
Boceprevir—Ill-defined disorder—Methotrexate—lung cancer	4.58e-05	0.000237	CcSEcCtD
Boceprevir—Tinnitus—Doxorubicin—lung cancer	4.57e-05	0.000236	CcSEcCtD
Boceprevir—Gastrointestinal pain—Docetaxel—lung cancer	4.57e-05	0.000236	CcSEcCtD
Boceprevir—Anaemia—Methotrexate—lung cancer	4.56e-05	0.000236	CcSEcCtD
Boceprevir—Flushing—Doxorubicin—lung cancer	4.55e-05	0.000235	CcSEcCtD
Boceprevir—Cardiac disorder—Doxorubicin—lung cancer	4.55e-05	0.000235	CcSEcCtD
Boceprevir—Diarrhoea—Paclitaxel—lung cancer	4.51e-05	0.000233	CcSEcCtD
Boceprevir—Angiopathy—Doxorubicin—lung cancer	4.45e-05	0.00023	CcSEcCtD
Boceprevir—Malaise—Methotrexate—lung cancer	4.45e-05	0.00023	CcSEcCtD
Boceprevir—Dizziness—Etoposide—lung cancer	4.44e-05	0.00023	CcSEcCtD
Boceprevir—Immune system disorder—Doxorubicin—lung cancer	4.43e-05	0.000229	CcSEcCtD
Boceprevir—Vertigo—Methotrexate—lung cancer	4.43e-05	0.000229	CcSEcCtD
Boceprevir—Mediastinal disorder—Doxorubicin—lung cancer	4.42e-05	0.000229	CcSEcCtD
Boceprevir—Abdominal pain—Docetaxel—lung cancer	4.41e-05	0.000228	CcSEcCtD
Boceprevir—Body temperature increased—Docetaxel—lung cancer	4.41e-05	0.000228	CcSEcCtD
Boceprevir—Leukopenia—Methotrexate—lung cancer	4.41e-05	0.000228	CcSEcCtD
Boceprevir—Chills—Doxorubicin—lung cancer	4.4e-05	0.000228	CcSEcCtD
Boceprevir—Arrhythmia—Doxorubicin—lung cancer	4.38e-05	0.000227	CcSEcCtD
Boceprevir—Dizziness—Paclitaxel—lung cancer	4.36e-05	0.000225	CcSEcCtD
Boceprevir—Nausea—Cisplatin—lung cancer	4.36e-05	0.000225	CcSEcCtD
Boceprevir—Alopecia—Doxorubicin—lung cancer	4.33e-05	0.000224	CcSEcCtD
Boceprevir—Cough—Methotrexate—lung cancer	4.3e-05	0.000222	CcSEcCtD
Boceprevir—Mental disorder—Doxorubicin—lung cancer	4.3e-05	0.000222	CcSEcCtD
Boceprevir—Vomiting—Etoposide—lung cancer	4.27e-05	0.000221	CcSEcCtD
Boceprevir—Malnutrition—Doxorubicin—lung cancer	4.27e-05	0.000221	CcSEcCtD
Boceprevir—Erythema—Doxorubicin—lung cancer	4.27e-05	0.000221	CcSEcCtD
Boceprevir—Rash—Etoposide—lung cancer	4.24e-05	0.000219	CcSEcCtD
Boceprevir—Dermatitis—Etoposide—lung cancer	4.23e-05	0.000219	CcSEcCtD
Boceprevir—Headache—Etoposide—lung cancer	4.21e-05	0.000218	CcSEcCtD
Boceprevir—Flatulence—Doxorubicin—lung cancer	4.21e-05	0.000218	CcSEcCtD
Boceprevir—Arthralgia—Methotrexate—lung cancer	4.2e-05	0.000217	CcSEcCtD
Boceprevir—Chest pain—Methotrexate—lung cancer	4.2e-05	0.000217	CcSEcCtD
Boceprevir—Myalgia—Methotrexate—lung cancer	4.2e-05	0.000217	CcSEcCtD
Boceprevir—Vomiting—Paclitaxel—lung cancer	4.19e-05	0.000217	CcSEcCtD
Boceprevir—Dysgeusia—Doxorubicin—lung cancer	4.18e-05	0.000216	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	4.17e-05	0.000216	CcSEcCtD
Boceprevir—Rash—Paclitaxel—lung cancer	4.15e-05	0.000215	CcSEcCtD
Boceprevir—Dermatitis—Paclitaxel—lung cancer	4.15e-05	0.000215	CcSEcCtD
Boceprevir—Discomfort—Methotrexate—lung cancer	4.15e-05	0.000214	CcSEcCtD
Boceprevir—Back pain—Doxorubicin—lung cancer	4.13e-05	0.000214	CcSEcCtD
Boceprevir—Headache—Paclitaxel—lung cancer	4.13e-05	0.000213	CcSEcCtD
Boceprevir—Hypersensitivity—Docetaxel—lung cancer	4.11e-05	0.000213	CcSEcCtD
Boceprevir—Muscle spasms—Doxorubicin—lung cancer	4.11e-05	0.000212	CcSEcCtD
Boceprevir—Confusional state—Methotrexate—lung cancer	4.06e-05	0.00021	CcSEcCtD
Boceprevir—Vision blurred—Doxorubicin—lung cancer	4.02e-05	0.000208	CcSEcCtD
Boceprevir—Asthenia—Docetaxel—lung cancer	4.01e-05	0.000207	CcSEcCtD
Boceprevir—Infection—Methotrexate—lung cancer	4e-05	0.000207	CcSEcCtD
Boceprevir—Nausea—Etoposide—lung cancer	3.99e-05	0.000206	CcSEcCtD
Boceprevir—Ill-defined disorder—Doxorubicin—lung cancer	3.96e-05	0.000205	CcSEcCtD
Boceprevir—Pruritus—Docetaxel—lung cancer	3.95e-05	0.000204	CcSEcCtD
Boceprevir—Nervous system disorder—Methotrexate—lung cancer	3.95e-05	0.000204	CcSEcCtD
Boceprevir—Anaemia—Doxorubicin—lung cancer	3.95e-05	0.000204	CcSEcCtD
Boceprevir—Thrombocytopenia—Methotrexate—lung cancer	3.94e-05	0.000204	CcSEcCtD
Boceprevir—Agitation—Doxorubicin—lung cancer	3.92e-05	0.000203	CcSEcCtD
Boceprevir—Nausea—Paclitaxel—lung cancer	3.91e-05	0.000202	CcSEcCtD
Boceprevir—Skin disorder—Methotrexate—lung cancer	3.91e-05	0.000202	CcSEcCtD
Boceprevir—Hyperhidrosis—Methotrexate—lung cancer	3.89e-05	0.000201	CcSEcCtD
Boceprevir—Malaise—Doxorubicin—lung cancer	3.85e-05	0.000199	CcSEcCtD
Boceprevir—Vertigo—Doxorubicin—lung cancer	3.84e-05	0.000198	CcSEcCtD
Boceprevir—Syncope—Doxorubicin—lung cancer	3.83e-05	0.000198	CcSEcCtD
Boceprevir—Leukopenia—Doxorubicin—lung cancer	3.82e-05	0.000198	CcSEcCtD
Boceprevir—Diarrhoea—Docetaxel—lung cancer	3.82e-05	0.000198	CcSEcCtD
Boceprevir—Palpitations—Doxorubicin—lung cancer	3.77e-05	0.000195	CcSEcCtD
Boceprevir—Hypotension—Methotrexate—lung cancer	3.76e-05	0.000194	CcSEcCtD
Boceprevir—Loss of consciousness—Doxorubicin—lung cancer	3.75e-05	0.000194	CcSEcCtD
Boceprevir—Cough—Doxorubicin—lung cancer	3.73e-05	0.000193	CcSEcCtD
Boceprevir—Dizziness—Docetaxel—lung cancer	3.69e-05	0.000191	CcSEcCtD
Boceprevir—Hypertension—Doxorubicin—lung cancer	3.69e-05	0.000191	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Methotrexate—lung cancer	3.67e-05	0.00019	CcSEcCtD
Boceprevir—Insomnia—Methotrexate—lung cancer	3.64e-05	0.000188	CcSEcCtD
Boceprevir—Myalgia—Doxorubicin—lung cancer	3.64e-05	0.000188	CcSEcCtD
Boceprevir—Arthralgia—Doxorubicin—lung cancer	3.64e-05	0.000188	CcSEcCtD
Boceprevir—Chest pain—Doxorubicin—lung cancer	3.64e-05	0.000188	CcSEcCtD
Boceprevir—Anxiety—Doxorubicin—lung cancer	3.62e-05	0.000187	CcSEcCtD
Boceprevir—Paraesthesia—Methotrexate—lung cancer	3.61e-05	0.000187	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	3.61e-05	0.000187	CcSEcCtD
Boceprevir—Discomfort—Doxorubicin—lung cancer	3.59e-05	0.000186	CcSEcCtD
Boceprevir—Dyspnoea—Methotrexate—lung cancer	3.59e-05	0.000185	CcSEcCtD
Boceprevir—Dry mouth—Doxorubicin—lung cancer	3.56e-05	0.000184	CcSEcCtD
Boceprevir—Vomiting—Docetaxel—lung cancer	3.55e-05	0.000184	CcSEcCtD
Boceprevir—Dyspepsia—Methotrexate—lung cancer	3.54e-05	0.000183	CcSEcCtD
Boceprevir—Rash—Docetaxel—lung cancer	3.52e-05	0.000182	CcSEcCtD
Boceprevir—Dermatitis—Docetaxel—lung cancer	3.52e-05	0.000182	CcSEcCtD
Boceprevir—Confusional state—Doxorubicin—lung cancer	3.51e-05	0.000182	CcSEcCtD
Boceprevir—Decreased appetite—Methotrexate—lung cancer	3.5e-05	0.000181	CcSEcCtD
Boceprevir—Headache—Docetaxel—lung cancer	3.5e-05	0.000181	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Methotrexate—lung cancer	3.47e-05	0.00018	CcSEcCtD
Boceprevir—Fatigue—Methotrexate—lung cancer	3.47e-05	0.000179	CcSEcCtD
Boceprevir—Infection—Doxorubicin—lung cancer	3.46e-05	0.000179	CcSEcCtD
Boceprevir—Pain—Methotrexate—lung cancer	3.44e-05	0.000178	CcSEcCtD
Boceprevir—Shock—Doxorubicin—lung cancer	3.43e-05	0.000177	CcSEcCtD
Boceprevir—Nervous system disorder—Doxorubicin—lung cancer	3.42e-05	0.000177	CcSEcCtD
Boceprevir—Thrombocytopenia—Doxorubicin—lung cancer	3.41e-05	0.000176	CcSEcCtD
Boceprevir—Tachycardia—Doxorubicin—lung cancer	3.4e-05	0.000176	CcSEcCtD
Boceprevir—Skin disorder—Doxorubicin—lung cancer	3.38e-05	0.000175	CcSEcCtD
Boceprevir—Hyperhidrosis—Doxorubicin—lung cancer	3.37e-05	0.000174	CcSEcCtD
Boceprevir—Nausea—Docetaxel—lung cancer	3.32e-05	0.000171	CcSEcCtD
Boceprevir—Feeling abnormal—Methotrexate—lung cancer	3.32e-05	0.000171	CcSEcCtD
Boceprevir—Gastrointestinal pain—Methotrexate—lung cancer	3.29e-05	0.00017	CcSEcCtD
Boceprevir—Hypotension—Doxorubicin—lung cancer	3.26e-05	0.000168	CcSEcCtD
Boceprevir—Urticaria—Methotrexate—lung cancer	3.2e-05	0.000165	CcSEcCtD
Boceprevir—Body temperature increased—Methotrexate—lung cancer	3.18e-05	0.000164	CcSEcCtD
Boceprevir—Abdominal pain—Methotrexate—lung cancer	3.18e-05	0.000164	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Doxorubicin—lung cancer	3.17e-05	0.000164	CcSEcCtD
Boceprevir—Insomnia—Doxorubicin—lung cancer	3.15e-05	0.000163	CcSEcCtD
Boceprevir—Paraesthesia—Doxorubicin—lung cancer	3.13e-05	0.000162	CcSEcCtD
Boceprevir—Dyspnoea—Doxorubicin—lung cancer	3.11e-05	0.000161	CcSEcCtD
Boceprevir—Dyspepsia—Doxorubicin—lung cancer	3.07e-05	0.000159	CcSEcCtD
Boceprevir—Decreased appetite—Doxorubicin—lung cancer	3.03e-05	0.000157	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Doxorubicin—lung cancer	3.01e-05	0.000156	CcSEcCtD
Boceprevir—Fatigue—Doxorubicin—lung cancer	3e-05	0.000155	CcSEcCtD
Boceprevir—Pain—Doxorubicin—lung cancer	2.98e-05	0.000154	CcSEcCtD
Boceprevir—Constipation—Doxorubicin—lung cancer	2.98e-05	0.000154	CcSEcCtD
Boceprevir—Hypersensitivity—Methotrexate—lung cancer	2.96e-05	0.000153	CcSEcCtD
Boceprevir—Asthenia—Methotrexate—lung cancer	2.89e-05	0.000149	CcSEcCtD
Boceprevir—Feeling abnormal—Doxorubicin—lung cancer	2.87e-05	0.000148	CcSEcCtD
Boceprevir—Gastrointestinal pain—Doxorubicin—lung cancer	2.85e-05	0.000147	CcSEcCtD
Boceprevir—Pruritus—Methotrexate—lung cancer	2.85e-05	0.000147	CcSEcCtD
Boceprevir—Urticaria—Doxorubicin—lung cancer	2.77e-05	0.000143	CcSEcCtD
Boceprevir—Abdominal pain—Doxorubicin—lung cancer	2.75e-05	0.000142	CcSEcCtD
Boceprevir—Body temperature increased—Doxorubicin—lung cancer	2.75e-05	0.000142	CcSEcCtD
Boceprevir—Diarrhoea—Methotrexate—lung cancer	2.75e-05	0.000142	CcSEcCtD
Boceprevir—Dizziness—Methotrexate—lung cancer	2.66e-05	0.000138	CcSEcCtD
Boceprevir—Hypersensitivity—Doxorubicin—lung cancer	2.57e-05	0.000133	CcSEcCtD
Boceprevir—Vomiting—Methotrexate—lung cancer	2.56e-05	0.000132	CcSEcCtD
Boceprevir—Rash—Methotrexate—lung cancer	2.54e-05	0.000131	CcSEcCtD
Boceprevir—Dermatitis—Methotrexate—lung cancer	2.54e-05	0.000131	CcSEcCtD
Boceprevir—Headache—Methotrexate—lung cancer	2.52e-05	0.00013	CcSEcCtD
Boceprevir—Asthenia—Doxorubicin—lung cancer	2.5e-05	0.000129	CcSEcCtD
Boceprevir—Pruritus—Doxorubicin—lung cancer	2.47e-05	0.000127	CcSEcCtD
Boceprevir—Nausea—Methotrexate—lung cancer	2.39e-05	0.000124	CcSEcCtD
Boceprevir—Diarrhoea—Doxorubicin—lung cancer	2.38e-05	0.000123	CcSEcCtD
Boceprevir—Dizziness—Doxorubicin—lung cancer	2.3e-05	0.000119	CcSEcCtD
Boceprevir—Vomiting—Doxorubicin—lung cancer	2.22e-05	0.000115	CcSEcCtD
Boceprevir—Rash—Doxorubicin—lung cancer	2.2e-05	0.000114	CcSEcCtD
Boceprevir—Dermatitis—Doxorubicin—lung cancer	2.2e-05	0.000113	CcSEcCtD
Boceprevir—Headache—Doxorubicin—lung cancer	2.18e-05	0.000113	CcSEcCtD
Boceprevir—Nausea—Doxorubicin—lung cancer	2.07e-05	0.000107	CcSEcCtD
Boceprevir—CTSS—Immune System—JUN—lung cancer	1.62e-05	0.000109	CbGpPWpGaD
Boceprevir—CTSV—Immune System—PIK3CA—lung cancer	1.62e-05	0.000109	CbGpPWpGaD
Boceprevir—CTSL—Immune System—PIK3CA—lung cancer	1.62e-05	0.000109	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—ERBB2—lung cancer	1.62e-05	0.000109	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	1.61e-05	0.000108	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MTOR—lung cancer	1.6e-05	0.000107	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PIK3CB—lung cancer	1.6e-05	0.000107	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—GSTP1—lung cancer	1.6e-05	0.000107	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—GNG11—lung cancer	1.6e-05	0.000107	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTM2—lung cancer	1.59e-05	0.000107	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CNDP2—lung cancer	1.59e-05	0.000107	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CDKN1A—lung cancer	1.57e-05	0.000105	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	1.57e-05	0.000105	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PTEN—lung cancer	1.57e-05	0.000105	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—AKT1—lung cancer	1.55e-05	0.000104	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—MTMR3—lung cancer	1.55e-05	0.000104	CbGpPWpGaD
Boceprevir—CTSK—Immune System—EGFR—lung cancer	1.55e-05	0.000104	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CXCL8—lung cancer	1.54e-05	0.000103	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	1.51e-05	0.000101	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PGAM1—lung cancer	1.51e-05	0.000101	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	1.51e-05	0.000101	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PLBD1—lung cancer	1.5e-05	0.000101	CbGpPWpGaD
Boceprevir—CTSV—Immune System—HRAS—lung cancer	1.5e-05	0.000101	CbGpPWpGaD
Boceprevir—CTSL—Immune System—HRAS—lung cancer	1.5e-05	0.000101	CbGpPWpGaD
Boceprevir—CTSS—Immune System—EP300—lung cancer	1.5e-05	0.0001	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—AKT1—lung cancer	1.49e-05	9.99e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CASP3—lung cancer	1.47e-05	9.86e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL2—lung cancer	1.47e-05	9.84e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—GSTM1—lung cancer	1.47e-05	9.82e-05	CbGpPWpGaD
Boceprevir—CTSK—Immune System—KRAS—lung cancer	1.46e-05	9.8e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—SRC—lung cancer	1.46e-05	9.75e-05	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—AKT1—lung cancer	1.45e-05	9.72e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	1.45e-05	9.68e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP2A7—lung cancer	1.44e-05	9.65e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	1.44e-05	9.63e-05	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL6—lung cancer	1.44e-05	9.63e-05	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL6—lung cancer	1.44e-05	9.63e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—ADCY1—lung cancer	1.43e-05	9.61e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—ABCG2—lung cancer	1.43e-05	9.61e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CCND1—lung cancer	1.43e-05	9.6e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—JUN—lung cancer	1.43e-05	9.58e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SDC4—lung cancer	1.41e-05	9.44e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—STAT3—lung cancer	1.4e-05	9.4e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—NRAS—lung cancer	1.4e-05	9.38e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MMP9—lung cancer	1.39e-05	9.32e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—CYP1A1—lung cancer	1.39e-05	9.31e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CDKN1A—lung cancer	1.39e-05	9.28e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PTEN—lung cancer	1.38e-05	9.26e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HSD17B10—lung cancer	1.38e-05	9.21e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	1.37e-05	9.18e-05	CbGpPWpGaD
Boceprevir—CTSK—Immune System—PIK3CA—lung cancer	1.35e-05	9.01e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—MAPK3—lung cancer	1.34e-05	8.98e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—TF—lung cancer	1.33e-05	8.93e-05	CbGpPWpGaD
Boceprevir—CTSV—Immune System—AKT1—lung cancer	1.33e-05	8.88e-05	CbGpPWpGaD
Boceprevir—CTSL—Immune System—AKT1—lung cancer	1.33e-05	8.88e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—EP300—lung cancer	1.32e-05	8.83e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—RRM1—lung cancer	1.28e-05	8.6e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTA3—lung cancer	1.28e-05	8.6e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—SRC—lung cancer	1.28e-05	8.59e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	1.28e-05	8.57e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CKB—lung cancer	1.28e-05	8.56e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—EGFR—lung cancer	1.28e-05	8.55e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	1.28e-05	8.54e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	1.26e-05	8.45e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—VEGFA—lung cancer	1.25e-05	8.37e-05	CbGpPWpGaD
Boceprevir—CTSK—Immune System—HRAS—lung cancer	1.24e-05	8.33e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—STAT3—lung cancer	1.24e-05	8.28e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NRAS—lung cancer	1.23e-05	8.26e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	1.23e-05	8.26e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—COL4A3BP—lung cancer	1.22e-05	8.19e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AZIN2—lung cancer	1.22e-05	8.19e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—B4GALT5—lung cancer	1.21e-05	8.09e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—KRAS—lung cancer	1.21e-05	8.07e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTM2—lung cancer	1.2e-05	8.05e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CNDP2—lung cancer	1.2e-05	8.05e-05	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL6—lung cancer	1.19e-05	7.98e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MAPK3—lung cancer	1.18e-05	7.91e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTA4—lung cancer	1.17e-05	7.87e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—MTMR3—lung cancer	1.17e-05	7.83e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MYC—lung cancer	1.15e-05	7.7e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	1.15e-05	7.67e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTA2—lung cancer	1.14e-05	7.67e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PGAM1—lung cancer	1.14e-05	7.63e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—EGFR—lung cancer	1.12e-05	7.53e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	1.11e-05	7.47e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	1.11e-05	7.45e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PIK3CA—lung cancer	1.11e-05	7.42e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTA1—lung cancer	1.1e-05	7.4e-05	CbGpPWpGaD
Boceprevir—CTSK—Immune System—AKT1—lung cancer	1.1e-05	7.36e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ABCC3—lung cancer	1.09e-05	7.31e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP2A7—lung cancer	1.09e-05	7.28e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	1.08e-05	7.22e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	1.08e-05	7.21e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SDC4—lung cancer	1.06e-05	7.13e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—KRAS—lung cancer	1.06e-05	7.11e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—AKR1C1—lung cancer	1.06e-05	7.08e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ATP5H—lung cancer	1.04e-05	6.96e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—POMC—lung cancer	1.04e-05	6.94e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—UGT1A1—lung cancer	1.03e-05	6.88e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	1.03e-05	6.87e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—HRAS—lung cancer	1.02e-05	6.86e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	9.98e-06	6.68e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GNG11—lung cancer	9.9e-06	6.63e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL6—lung cancer	9.81e-06	6.57e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PIK3CA—lung cancer	9.76e-06	6.53e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	9.72e-06	6.51e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—RRM1—lung cancer	9.69e-06	6.49e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTA3—lung cancer	9.69e-06	6.49e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TP53—lung cancer	9.44e-06	6.32e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ALDOA—lung cancer	9.43e-06	6.31e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PLBD1—lung cancer	9.27e-06	6.21e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—AVP—lung cancer	9.24e-06	6.19e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	9.19e-06	6.16e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NCOA3—lung cancer	9.15e-06	6.13e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—B4GALT5—lung cancer	9.11e-06	6.1e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—AKT1—lung cancer	9.05e-06	6.06e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—HRAS—lung cancer	9.03e-06	6.05e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	8.94e-06	5.99e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ABCG2—lung cancer	8.9e-06	5.96e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ADCY1—lung cancer	8.9e-06	5.96e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTA4—lung cancer	8.86e-06	5.94e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	8.75e-06	5.86e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—HPGDS—lung cancer	8.73e-06	5.85e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ENO2—lung cancer	8.73e-06	5.85e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PPP2R1B—lung cancer	8.68e-06	5.81e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL6—lung cancer	8.64e-06	5.79e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTA2—lung cancer	8.64e-06	5.78e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HSD17B10—lung cancer	8.48e-06	5.68e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTT1—lung cancer	8.47e-06	5.67e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GCLC—lung cancer	8.37e-06	5.61e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP2A6—lung cancer	8.37e-06	5.61e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTA1—lung cancer	8.33e-06	5.58e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	8.26e-06	5.53e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ABCC3—lung cancer	8.24e-06	5.52e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—AKR1C1—lung cancer	7.98e-06	5.34e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—AKT1—lung cancer	7.97e-06	5.34e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ENO1—lung cancer	7.93e-06	5.31e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CKB—lung cancer	7.88e-06	5.28e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—UGT1A1—lung cancer	7.75e-06	5.19e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	7.59e-06	5.08e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GNG11—lung cancer	7.47e-06	5e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CNDP2—lung cancer	7.41e-06	4.96e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTM2—lung cancer	7.41e-06	4.96e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	7.34e-06	4.92e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—MTMR3—lung cancer	7.21e-06	4.83e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP2E1—lung cancer	7.12e-06	4.77e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ALDOA—lung cancer	7.11e-06	4.76e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	7.07e-06	4.73e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NQO1—lung cancer	7.04e-06	4.71e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PGAM1—lung cancer	7.02e-06	4.7e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NCOA3—lung cancer	6.91e-06	4.62e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ADCY1—lung cancer	6.72e-06	4.5e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ABCG2—lung cancer	6.72e-06	4.5e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP2A7—lung cancer	6.7e-06	4.49e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HPGDS—lung cancer	6.59e-06	4.41e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ENO2—lung cancer	6.59e-06	4.41e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SDC4—lung cancer	6.56e-06	4.39e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PPP2R1B—lung cancer	6.55e-06	4.38e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTT1—lung cancer	6.39e-06	4.28e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—STK11—lung cancer	6.34e-06	4.25e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP2A6—lung cancer	6.32e-06	4.23e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GCLC—lung cancer	6.32e-06	4.23e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	6.2e-06	4.15e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ENO1—lung cancer	5.99e-06	4.01e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	5.98e-06	4.01e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTA3—lung cancer	5.97e-06	4e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—RRM1—lung cancer	5.97e-06	4e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTP1—lung cancer	5.87e-06	3.93e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CAT—lung cancer	5.71e-06	3.82e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—B4GALT5—lung cancer	5.61e-06	3.76e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	5.6e-06	3.75e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ABCB1—lung cancer	5.56e-06	3.72e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTA4—lung cancer	5.46e-06	3.66e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—TYMS—lung cancer	5.46e-06	3.65e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTM1—lung cancer	5.39e-06	3.61e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP2E1—lung cancer	5.37e-06	3.6e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTA2—lung cancer	5.32e-06	3.56e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NQO1—lung cancer	5.31e-06	3.56e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTA1—lung cancer	5.13e-06	3.44e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP1A1—lung cancer	5.11e-06	3.42e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ABCC3—lung cancer	5.08e-06	3.4e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ERCC2—lung cancer	5.07e-06	3.4e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	5.06e-06	3.39e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AKR1C1—lung cancer	4.92e-06	3.29e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—STK11—lung cancer	4.79e-06	3.21e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—UGT1A1—lung cancer	4.77e-06	3.2e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GNG11—lung cancer	4.6e-06	3.08e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTP1—lung cancer	4.43e-06	2.97e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—APOA1—lung cancer	4.39e-06	2.94e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ALDOA—lung cancer	4.38e-06	2.94e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CAT—lung cancer	4.31e-06	2.89e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NCOA3—lung cancer	4.25e-06	2.85e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ADCY1—lung cancer	4.14e-06	2.77e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ABCG2—lung cancer	4.14e-06	2.77e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—TYMS—lung cancer	4.12e-06	2.76e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTM1—lung cancer	4.07e-06	2.73e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ENO2—lung cancer	4.06e-06	2.72e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HPGDS—lung cancer	4.06e-06	2.72e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PPP2R1B—lung cancer	4.03e-06	2.7e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PIK3CG—lung cancer	4.01e-06	2.68e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTT1—lung cancer	3.94e-06	2.64e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GCLC—lung cancer	3.89e-06	2.61e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP2A6—lung cancer	3.89e-06	2.61e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP1A1—lung cancer	3.86e-06	2.58e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ERCC2—lung cancer	3.83e-06	2.56e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—POMC—lung cancer	3.81e-06	2.55e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CREBBP—lung cancer	3.71e-06	2.49e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ENO1—lung cancer	3.69e-06	2.47e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PIK3CD—lung cancer	3.52e-06	2.36e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ALB—lung cancer	3.48e-06	2.33e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—APOA1—lung cancer	3.31e-06	2.22e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP2E1—lung cancer	3.31e-06	2.22e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NQO1—lung cancer	3.27e-06	2.19e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PIK3CB—lung cancer	3.07e-06	2.06e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTGS2—lung cancer	3.04e-06	2.04e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PIK3CG—lung cancer	3.02e-06	2.02e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—STK11—lung cancer	2.95e-06	1.97e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—POMC—lung cancer	2.88e-06	1.93e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CREBBP—lung cancer	2.8e-06	1.88e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTP1—lung cancer	2.73e-06	1.83e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PIK3CD—lung cancer	2.66e-06	1.78e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CAT—lung cancer	2.66e-06	1.78e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTEN—lung cancer	2.65e-06	1.78e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ALB—lung cancer	2.62e-06	1.76e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ABCB1—lung cancer	2.58e-06	1.73e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—TYMS—lung cancer	2.54e-06	1.7e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—EP300—lung cancer	2.53e-06	1.69e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTM1—lung cancer	2.51e-06	1.68e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP1A1—lung cancer	2.38e-06	1.59e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ERCC2—lung cancer	2.36e-06	1.58e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PIK3CB—lung cancer	2.32e-06	1.55e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTGS2—lung cancer	2.29e-06	1.54e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—APOA1—lung cancer	2.04e-06	1.37e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTEN—lung cancer	2e-06	1.34e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—EP300—lung cancer	1.91e-06	1.28e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PIK3CA—lung cancer	1.87e-06	1.25e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PIK3CG—lung cancer	1.86e-06	1.25e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—POMC—lung cancer	1.77e-06	1.19e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CREBBP—lung cancer	1.73e-06	1.16e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PIK3CD—lung cancer	1.64e-06	1.1e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ALB—lung cancer	1.62e-06	1.08e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—AKT1—lung cancer	1.53e-06	1.02e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PIK3CB—lung cancer	1.43e-06	9.55e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTGS2—lung cancer	1.41e-06	9.47e-06	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PIK3CA—lung cancer	1.41e-06	9.45e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTEN—lung cancer	1.23e-06	8.26e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—EP300—lung cancer	1.18e-06	7.87e-06	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—AKT1—lung cancer	1.15e-06	7.72e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PIK3CA—lung cancer	8.7e-07	5.82e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AKT1—lung cancer	7.11e-07	4.76e-06	CbGpPWpGaD
